Isoelectric focusing of liver and brain extracts was successfully used to resolve several species of sphingomyelinase. Three (1-111) of the five species were partially characterized. Enzyme 1 (pl 4.6) had a pH optimum of 4.F5.0 in acetate buffer and a K, value of 0.026 mM. Both sphingomyelinases I and I1 were the major enzymes, whereas 111, IV, and V were found at lower levels. Of the two major species in normal liver and brain ( I and 111, species I alone persisted in liver from the two cases of type C, while species Ill, IV, and V were present. In brain, only species 11 was decreased but the resolution of the brain enzymes was less satisfactory.
Speculation
Sphingomyelinases exist in multiple molecular forms in human liver and brain. In Niemann-Pick disease, type C, a deficiency of a specific sphingomyelinase was noted in liver and brain from two patients. The lack of this enzyme probably reflects the genetic defect in this disease.
Niemann-Pick disease exists as several distinct clinical and biochemical entities, all of which are characterized by the accumulation of sphingomyelin in the major visceral organs. All types of Niemann-Pick disease differ, however, with respect to degree of sphingomyelin storage in the viscera and nervous system, age o f onset and death, and severity of neurologic abnornialities (7) . Although sphingolnyelin storage bears a primary relationship to the genetic defects in these diseases, the reasons for storage of other lipids such as cholesterol, bis(monoacylg1yceryl) phosphate, and several glycolipids in a variety of tissues are poorly understood (13. 14, 17, 18). Sphingomyelinase (sphingomyelin phosphodie.;terase. EC. 3.1.4.12) is virtually absent in type A, is reduced to about 107% of normal in liver and spleen of type B patients and is near normal in most tissues in type C (2, 20, 21) .
The variability of clinical and biochemical expression led us to the view that multiple species of sphingomyelinase must exist in human tissues and that defects in one or more of these forms probably underlined the various types of this disease. Lowden and La Ramee (10) suggested previously the presence of at least two species of sphingomyelinase in human liver.
A recent report from this laboratory has demonstrated the presence of at least two major species of sphingomyelinase in human liver, one of which was absent from the liver of a patient with Niemann-Pick disease. type C (5) . In this report. we wish to present additional data on the liver enzymes and extend our observations to the brain of two additional cases of type C . A preliminary report of this work has appeared (6).
MATERIALS AND METHODS C A S E MATERIAL
Autopsy specimens of liver and brain were obtained within 24 hr of death and stored at -20' in closed containers until used. Liver and brain from two cases of type C Niemann-Pick disease were also analyzed. Case I (TA) had markedly delayed milestones, she was deaf, and developed cerebellar ataxia before death at 7 years of age. She was found to have hepatosplenomegaly in infancy. Numerous foam cells were observed in the bone marrow but there were no sea-blue histiocytes. G , , and G ,, gangliosides were increased in the cortex and the white matter. Sphingomyelin content of the liver and spleen was 3.4 and 9.3 mg/g wet weight compared with normal values of 1.1 and 2.5 mg/g wet weight, respectively. The sphingomyelin content of brain gray and white matter was normal. Case 2 (FM) died at the age of 5 and details on this patient have been presented (17) . Data on the neutral and acidic glycolipid levels in liver and spleen from both patients have been reported elsewhere (16) . crystalline bovine serum albumin were purchased froni Siyni:~ Chemical Co. (24) . Reagent cgrade sucrose was purchased froni Fisher Scientific (25) . and the carrier ampholines were a product of LKB Instruments (26).
T I S S U E EXTRACTION
The procedure used for preparation of the tissue extracts was the same as reported earlier (5 ISOELECTRIC FOCUSING lsoelectric focusing was carried out on the combined supernatant fluids in a Uniphor 7900 column electrophoresis system (27) . The enzyme extract containing 40-50 mg and 20-26 mg protein for liver and brain, respectively, was exposed to current for 40 4 4 hr at a maximum voltage of 600 V in the presence of a sucrose gradient and 3% carrier ampholines, pH range 4-7. The temperature was thermostatically maintained at 3.0-4.0'. The column was eluted from below at a flow rate of 1 nil/min and 0.8-1.0-ml fractions (25 dropsltube) were collected. Enzyme activities were measured in the presence of ampholines and sucrose. The pH of the fractions was measured with a combination microelectrode in an ice bath.
E N Z Y M E ASSAYS
Tritium-labeled sphingomyelin was purified as described previously (5). Sphingomyelinase was measured according to the method of Schneider and Kennedy (20) . The assay mixture contained, in a final volume of 0. 
RESULTS

INITIAL S T U D I E S
Sphingomyelinase and two other acid hydrolases, P-hexosaminidase and P-galactosidase, were measured in several control specimens and the two cases of type C (Table I ). The three enzymes appear to be stable for several years when the tissue is stored in the frozen state, in agreement with other workers (2, 20) . Total sphingomyelinase in brain and liver of type C was generally within the range of the controls. There does not seem to be any age dependence of the liver o r brain sphingomyelinase levels.
T h e double extraction procedure employed brought a t least 90T1 of the sphingomyelinase activity into solution in the control samples and a t least 86% of the total in the type C tissues. Only the activities in the initial extraction a r e shown (Table 2 ). In general.
of the total enzyme recovered. about 8 5 9 0 % was obtained in the first supernatant with the remainder recovered on rehomogenization of the residue. Over 90% of the P-hexosaminidase and P-galactosidase was also solubilized by this technique. in agreement with the d a t a of Sandhoff et al. (19) . A nonenzymatic protein precipitate which formed on dialysis of the supernatant fluids ' Liver (1 g) and brain (2 g) from normal and diseased patients were homogenized in buffer as described. The supernatant fluids were used as enzyme source. All numbers are averages of measurements taken at five protein concentrations. @-Hex: P-hexosaminidase: ,!&Gal: @-galactosidase.
Nanomoles of sphingomyelin hydrolyzed or nitrophenol released per hr per mg protein.
against 1% glycine was removed by centrifugation. There was little loss of sphingomyelinase by this method and a noticeable improvement in the linearity of the reaction (Fig. I) . In the crude homogenate, sphingomyelinase activity deviated from linearity a t protein concentrations above 100 p g in the normal and diseased tissues. After centrifugation and dialysis linearity was improved.
although the improvement was less striking in the type C liver. T h e s a m e observations were made with brain extracts prepared in the s a m e manner. After dialysis against glycine, the specific activity was about 6-fold higher than in the crude extract from normal subjects but only 3-fold increased in the type C liver. T h e net PROTEIN) Liver (I g) and brain (2 g) were homogenized as described. Aliquots of the final dialyzed supernatant fluids were pooled and subjected to electrofocusing. Sp Act: specific activity. increase in specific activity in control and type C brain extracts was 9.5-and 15-fold. respectively.
Equal aliquots of supernatant fluids and the diulyred extracts prepared from control and type C liver and brain were mised and sphinpomyclinase was determined. There was no difference from the expected values. These results are in asreenicnt with those of other workers (20) .
IDENTIFICATION OF S P H I N G O M Y E L I N 4 S F S IN N O R M A L A N D NIEMANN-PICK TYPE C LIVER A N D BRAIN
Several species of sphinpomyelinase have been identified in human liver (Fig. 2) . The r n~~j o r peaks of activity (enrymes I and 11) were found at pl 4.7 and 4.9. respectively. in apreement with previous work (5. 6). An addilional peak was found at pl 5.1 and this species has been desipnated enzyme I l l . Minor amounts of enzyme were located at pl 5.8 and near the top of the gradient (near pl 7.1). These are designated sphingoniyelinuses IV and V.
respectively. Under the experimental conditions employed, Phexosaminidases A and B have isoelectric points at 4.9 and 7.1-7.4, respectia,ely. whereas the majority o f t h e P-pal~ictosidase has an isoelectric point of 4.3 4.7. Recovery of sphingomyelinase and P-he.xos;~minidase activities was 90-95"r8. Dialysis overnight against I"r glycinc reduced fi-galnctosidase activitk to a verb lo* level before elcctrofocusing, and recoveries were poor. We have shown previously in refocusing experiments that sphingornyelinases I, 11, and 111 possess distinct isoelectric points and pH optima (5) . These species difSer slightly in their apparent K, values at the pH optiliiurn (Table 3) . Enryrne I was found to have a K, of 0.026 m M in three different control livers at pH 5.0. whereas both I1 and 111 have a K, value of 0.014 at pH 4.0.
Neither species IV nor V has been studied to date.
Both liver and brain of Niemann-Pick disease type C have been analyzed (Figs. 2 and 3 ). In the liver of case 2, enzyme I (pl 4.7) was prominent and species I1 was substantially reduced (Fig. 2) .
Species I l l and IV were also low in the liver of this patient. Species I was ~ilso the most prominent species in liver of case I. Again. I I and I l l were lower than normal. In both cases. enzyme V persisted. In control experiments there was no difference in the distribution of sphingornyelinases obtained from the first tissue hornopenization compared with that obtained upon re-extraction of the tissue.
In addition. there w:is no difference in species I and I 1 in both control liver and liver from type C between extracts run before and after dialysis against 1% glycine. This rules out selective loss o f specific enzymes due t o the extraction procedures employed.
Sphingomyelinase I isolated from the liver of cast. 2 has the same FRACTION NUMBER Fig. 2 . Sphingomyelinase isoenzymes in normal liver and In Niemann-Pick. type C. The extracts were prepared from I g frozen liver and analyzed separately. Normal liver (lowerpanel) is compared with liver from case I (upperpanel) and from case 2 (middle panel). The isoelectric points of the major peaks are indicated. Recovery was 85, 65, and 78% for the normal. cases I and 2 , respectively. The pH gradient is the solid line. 9) were found in the normal but were incompletely resolved. In the diseased hrain. only the first major peak (pl 4.5) was prominent. Recovery of activity i n all instances was over 90%. The solid line represents the pH gradient. pH optimum and K, value as isoenzynie 1 of normal liver (Table   3 ).
In the brain. multiple peaks of sphingornyelin;~se activity were also seen although the resolution obtained was not its good :IS in liver. Sphingomyelinase I , with a pl of 4.5 4.7. was thc most prominent species discerned. A small peak was seen in all of the brain samples tested at pl values between 3.6 and 4.1. In the type C brain samples. there was peaking at pl values between 4.3 and 4.7, whereas in the control presented. a single peak at a pl of4.7 is shown. In the control (Fig. 3) . additional peaks of activit! are ' present at pl 5.0 and at pl 5.4, at pl 6.0 and at pl 7.6. The latter three enzymes have been designated I l l . IV. and V. respectively. and probably correspond to the sanie enrynies seen in liver. The peak at pl 5.0 (sphingomyelinase 11) was reduced in both brain specimens from type C. .Although the loss of this enzyme is less strikinp than in liver. it nevertheless does suggest that a specific deficiency of sphingomyclinase I 1 exists in hrain as in liver in Niemann-Pick diseuse type C. confusing. we have reverted to the present usage. The various species of sphingomyelinase have not been well characterired and little is known h bout the structur;tl relationships between the species recopnized to date. In preliminarc experiments extracts from normal and type C liver were prepared separ:~tcly and [nixed before electrofocusing or were homogenired together and then focused. In both instances. species I was higher than 11. whereas Ill. IV, and V were unchanged. This suggests that each species is a separate and distinct enryme.
We have recently analyzed :i specimen of liver from LI case of Niemann-Pick disease type-B (4). Sphingomyelinases I-IV were present but were reduced to barely detectable levels. Only species V persisted at or near the normal level. Althouph preliminary. these d;lta d o suggest that sphingomyclinases I-IV may be related structurally. This observation has been confirmed in cultured fibroblasts derived froni another patient with type B (3). I t remains unclear whether the various species of sphingomyelinase recognized in this work can be called isoenryrnes and we have attempted to avoid this usage.
Several authors have noted that sphingomyelin storage is moderate in liver and spleen in type C when compared with the massive deposition found in these organs in types A and B (7. 14. 20) . Sphingoniyelin is the only known substrate for all species of sphingomyelinase in all tissues. and in Niemann-Pick disease type C. sphingoniyelin storage occurs in certain tissues in the presence of normal or elevated amounts of one major enzyme species which hydrolyzes the lipid in llitro. T o reconcile this dilemma we must assume that all species of sphingomyelinase are required for normal catabolism of this lipid in l~ivo. The absence of sphingornyelinase 11 may be sufficiently severe to upset the metabolic ~tlance such that c;ttabolic demand out\\eighs the capacity for reakdown. In the liver. this leads to ~ccumulation of sphinoniyelin at a moderate rate presumably due to the active role of 'ie liver and other lymphoid tissues such as spleen in endocytosis 15 (20) . which nay be Iargelq inactive in the present :tss:ty system. Sphingomyelinnse is principally but not exclusivel) a iysosonial :nzyme ( 1 . 9. 20. 22). Specific enrichment of sphingomyelin in rriton-loaded Iysosomes has been demonstrated in rat liver ( 1 3 ) . Ilnfortuantely. no data on the distribution of sphingoniyelinuse .vere presented in the latter study. It is possible that storage of ,phinponiyelin lends t o formation of residual bodies and to a loss ,)f several l>sosomal hydrolases. including sphingomyelinase, thus decreasing net hqdrolysis of rnernbrane components. Louden :~nd La Raniee (10, I I ) have found that sphingomyelinase in liver from a patient with type C was largely soluble compared with frozen normal liver controls in which only 4 0 5 of (he enzyme w:ts soluble.
Complete explanation of the apparent discrepanck between
.;phingoniyelin storage in type C and the presence of ample amounts of one major species which hydrolyzes (he lipid ilr 1,irro canno1 be m;tde :~t the present time. It is hoped that further work on subcellular fractionation and churacteriration of the multiple I'ortns of sphingomyelinase will elucidate these questions.
SUMMARY
Sphingoniqelinase can be resolved into at least five species by isoelectric focusing of human tissues. Each enLyrne has a chsritcteristic isoelectric point but all those tested have similar K, values.
Of the two major species in liver and brain. a specific deficiency of sphingomyelinase I1 was detected in liver and brain from two patients afflicted with Nieniann-Pick diseuse. type C.
